In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium abscessus Complex | Zendy

Barbara A. BrownElliott | Zendy; Richard J. Wallace | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium abscessus Complex

Author(s) -

Barbara A. BrownElliott,

Richard J. Wallace

Publication year - 2018

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01919-18

Subject(s) - mycobacterium abscessus , bedaquiline , microbiology and biotechnology , nontuberculous mycobacteria , tigecycline , medicine , broth microdilution , amikacin , virology , antibiotics , biology , mycobacterium , minimum inhibitory concentration , tuberculosis , mycobacterium tuberculosis , pathology

We performed bedaquiline broth microdilution susceptibility testing using Clinical and Laboratory Standards Institute (CLSI) guidelines on 104 nonduplicate isolates ofMycobacterium abscessus complex [M. abscessus subsp.abscessus (76);M. abscessus subsp.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research